21 /100
LOW RISK
Score updated May 28, 2026

MGX — Metagenomi Therapeutics, Inc. Dilution Risk Tracker

Track MGX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track MGX — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
25
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

Watch
Minor dilution signals detected
15%
🔄 Reverse Split 30%
• 50-day avg $1.39 approaching $1 threshold
🔔 Track MGX — Get forecast alerts →

💹 Market Data

Market Cap$50.82M
Shares Outstanding37.65M
Float27.35M
Cash$25.31M
Debt$39.19M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 4.4% shares (2025Q4 vs prior)
56 institutional holders · 6.85M shares
#1 VANGUARD GROUP INC 1.27M shares
#2 RENAISSANCE TECHNOLOGIES LLC 628.4K shares
#3 Catalio Capital Management, LP 529.0K shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest1.79M
Days to Cover9.9
% of Float6.5%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

No recent SEC insights

📰 Recent News

No recent news
Track MGX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking MGX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for MGX
📊 MGX FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 MGX Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.